Status:

COMPLETED

Using GM-CSF as a Host Directed Therapeutic Against COVID-19

Lead Sponsor:

Singapore General Hospital

Conditions:

COVID

Sars-CoV2

Eligibility:

All Genders

21-80 years

Phase:

PHASE2

Brief Summary

The coronavirus disease 2019 (COVID-19) has rapidly become a pandemic. COVID-19 poses a mortality risk of 3-7%, rising to 20% in older patients with co-morbidities. Of all infected patients, 15-20% wi...

Detailed Description

The hypothesis of the proposed intervention is that GM-CSF has profound effects on antiviral immunity, can provide the stimulus to restore immune homeostasis in the lung with acute lung injury post CO...

Eligibility Criteria

Inclusion

  • SARS-CoV-2 PCR-confirmed COVID-19 infection
  • Presence of acute hypoxic respiratory failure defined as (either or both)
  • Saturation \< 94% on room air or requiring supplemental oxygen
  • PaO2/FiO2 below 350
  • Age 21-80
  • Able and willing to provide informed consent

Exclusion

  • Patients who are already on supplemental oxygen of FiO2 ≥ 0.4
  • Patients with known history of serious allergic reactions, including anaphylaxis, to human GM-CSF such as Leukine®, yeast-derived products, or any component of the product.
  • Mechanical ventilation before start of study
  • Patients enrolled in another investigational drug study
  • Pregnant or breastfeeding females (all female subjects of childbearing potential status must have negative pregnancy test at screening)
  • Patients with peripheral white blood cell count above 25,000 per microliter and/or active myeloid malignancy
  • Patients on high dose systemic steroids (\> 20mg methylprednisolone or equivalent)
  • Patients on lithium carbonate therapy
  • Patients with serum ferritin \>2000 mcg/ml (which will exclude ongoing HLH)

Key Trial Info

Start Date :

June 2 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 4 2022

Estimated Enrollment :

2 Patients enrolled

Trial Details

Trial ID

NCT04400929

Start Date

June 2 2020

End Date

February 4 2022

Last Update

May 10 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Singapore General Hospital

Singapore, Singapore